Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment
Resource Type
Abstract
Authors
Dale, David C. ; Alsina, Laia ; Azar, Antoine ; Badolato, Raffaele ; Bhandari, Ashish ; Belschner, Andrea ; Bertrand, Yves ; Cadavid, Diego ; Dickerson, Kathryn E. ; Ezra, Navid ; Hasle, Henrik ; Hoffman, Harold ; Jiang, Honghua ; Kang, Hyoung Jin ; Kiani-Alikhan, Sorena ; Kuijpers, Taco W. ; Kulagin, Aleksandr D. ; Langguth, Daman ; Levin, Carina ; MacLeod, Richard ; Neth, Olaf ; Peake, Jane ; Rodina, Yulia ; Sharathkumar, Anjali ; Shcherbina, Anna ; Tang, Weihua ; Vossen, Matthias G. ; Donadieu, Jean
Source
In Blood 23 November 2021 138 Supplement 1:4310-4310
Subject
Language
ISSN
0006-4971